AI Solutions for Healthcare
June 2023 AI Alert

June 2023 AI Alert

Jun 27, 2023 | Forensic AI Alerts

Weight-loss Drug Shortages: Breeding Ground for Fraud and Future Health Issues  Weight-loss drugs containing semaglutides, specifically Wegovy and Ozempic, have stolen headlines due to high demand and product shortages. Patients may seek alternative sources for...
May 2023 AI Alert

May 2023 AI Alert

May 30, 2023 | Forensic AI Alerts

Psychiatrists Performing Psychotherapy Evaluation & Management (E&M) Services  Recently, several of our business partners expressed concerns with increased utilization by psychiatrists performing psychotherapy services and billing a high-level of...
April 2023 AI Alert

April 2023 AI Alert

Apr 25, 2023 | Forensic AI Alerts

Telephone E&M Services: When to “Make the Call” for Records Requests Telephone E&M services, specifically CPT (Current Procedural Terminology) 99441-99443, were infrequently utilized prior to the pandemic.  After a thorough analysis, Codoxo...
March 2023 AI Alert

March 2023 AI Alert

Mar 28, 2023 | Forensic AI Alerts

Take a deep breath when reviewing asthma treatments When reviewing asthma treatments, Codoxo noted high utilization of chemotherapy injections by Allergy & Immunology specialists in association with medications to treat eosinophilic asthma and severe asthma. The...
February 2023 AI Alert

February 2023 AI Alert

Feb 27, 2023 | Forensic AI Alerts

Gains and Losses with Weight Loss Prescription Drugs   Three weight-loss drugs are approved by the FDA (Food and Drug Administration) for persons with type 2 diabetes and obesity, and the names of the generic drug are tirzepatide, liraglutide, and semaglutide....
January 2023 AI Alert

January 2023 AI Alert

Jan 30, 2023 | Forensic AI Alerts

Coding and Billing for Audio-Only Delivered Services using Modifier 93   The healthcare industry has experienced significant growth and adoption of telehealth services over the past several years, and with it, a new trend of delivering audio-only services to...